Status:
NOT_YET_RECRUITING
Outcomes of Image-guided High-dose-rate Uterovaginal Brachytherapy With Single Implantation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
LOCALLY ADVANCED CERVICAL CANCERS
Eligibility:
FEMALE
18+ years
Brief Summary
Background and Rationale: Locally advanced cervical cancer remains a major public health concern worldwide and in France. Standard-of-care management involves concurrent chemoradiotherapy followed by...
Detailed Description
Background and Rationale Cervical cancer remains a major global health concern, ranking among the leading causes of cancer-related mortality in women in low- and middle-income countries, but also pers...
Eligibility Criteria
Inclusion
- Women aged 18 years or older
- Diagnosis of locally advanced cervical cancer (squamous cell carcinoma, adenocarcinoma, or other)
- FIGO stage IB3-IV
- Treatment with chemoradiotherapy followed by uterovaginal brachytherapy with implantation in the operating room
- Informed and not opposed to the collection of her data for research purposes
Exclusion
- Lack of information regarding follow-up
- Patient under legal protection measures -
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT07213427
Start Date
December 1 2025
End Date
June 1 2026
Last Update
October 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.